{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:31:22Z","timestamp":1767177082862,"version":"build-2238731810"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T00:00:00Z","timestamp":1376870400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0071558","type":"journal-article","created":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T17:20:49Z","timestamp":1376932849000},"page":"e71558","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Seven-Year Surveillance of emm Types of Pediatric Group A Streptococcal Pharyngitis Isolates in Western Greece"],"prefix":"10.1371","volume":"8","author":[{"given":"George A.","family":"Syrogiannopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna N.","family":"Grivea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Al-Lahham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Panagiotou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra G.","family":"Tsantouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aspasia N.","family":"Michoula Ralf Ren\u00e9 Reinert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,8,19]]},"reference":[{"key":"ref1","unstructured":"Stevens DL (2000) Group A beta-hemolytic streptococci: virulence factors, pathogenesis, and spectrum of clinical infections. In: Stevens DL, Kaplan EL, editors. Streptococcal infections: clinical aspects, microbiology, and molecular pathogenesis. New York: Oxford University Press. 19\u201336."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.89.3.307","article-title":"Current knowledge of type-specific M antigens of group A streptococci","volume":"89","author":"RC Lancefield","year":"1962","journal-title":"J Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/292457a0","article-title":"Type-specific protective immunity evoked by synthetic peptide of <italic>Streptococcus pyogenes<\/italic> M protein","volume":"292","author":"EH Beachey","year":"1981","journal-title":"Nature (London)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1084\/jem.161.3.623","article-title":"Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein","volume":"161","author":"KF Jones","year":"1985","journal-title":"J Exp Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1084\/jem.163.5.1191","article-title":"Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein","volume":"163","author":"JB Dale","year":"1986","journal-title":"J Exp Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/JCM.34.4.953-958.1996","article-title":"Sequencing <italic>emm<\/italic>-specific PCR products for routine and accurate typing of group A streptococci","volume":"34","author":"B Beall","year":"1996","journal-title":"J Clin Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(03)00576-0","article-title":"Molecular basis of group A streptococcal virulence","volume":"3","author":"AL Bisno","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1086\/521263","article-title":"Group A streptococcus epidemiology and vaccine implications","volume":"45","author":"R Cohen-Poradosu","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/0264-410X(96)00050-3","article-title":"Recombinant, octavalent group A streptococcal M protein vaccine","volume":"14","author":"JB Dale","year":"1996","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0264-410X(98)00150-9","article-title":"Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments","volume":"17","author":"JB Dale","year":"1999","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/IAI.70.4.2171-2177.2002","article-title":"Immunogenicity of a 26-valent group A streptococcal vaccine","volume":"70","author":"MC Hu","year":"2002","journal-title":"Infect Immun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers","volume":"41","author":"SA McNeil","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1128\/AAC.48.9.3559-3562.2004","article-title":"Emergence of macrolide-resistant <italic>Streptococcus pyogenes<\/italic> strains in French children","volume":"48","author":"E Bingen","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.49.5.2109-2111.2005","article-title":"Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and <italic>emm<\/italic> types among <italic>Streptococcus pyogenes<\/italic> in Portugal","volume":"49","author":"C Silva-Costa","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1179\/joc.2007.19.5.500","article-title":"Susceptibilities of <italic>Streptococcus pyogenes<\/italic> and <italic>Streptococcus pneumoniae<\/italic> to macrolides and telithromycin: data from an Italian multicenter study","volume":"19","author":"A Mazzariol","year":"2007","journal-title":"J Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1471-2180-12-215","article-title":"Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of <italic>Streptococcus pyogenes<\/italic> isolates resistant to erythromycin and tetracycline in Spain (1994\u20132006)","volume":"12","author":"V Rubio-L\u00f3pez","year":"2012","journal-title":"BMC Microbiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1128\/AAC.50.1.256-261.2006","article-title":"Resistance to erythromycin and telithromycin in <italic>Streptococcus pyogenes<\/italic> isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis","volume":"50","author":"IN Grivea","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ijantimicag.2010.01.025","article-title":"Macrolide-resistant <italic>Streptococcus pyogenes<\/italic> in Central Greece: prevalence; mechanism and molecular identification","volume":"35","author":"E Malli","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/01.inf.0000138080.74674.a2","article-title":"Two dosages of clarithromycin for five days, amoxicillin\/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis","volume":"23","author":"GA Syrogiannopoulos","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/AAC.43.8.1935","article-title":"Phenotypes and genotypes of erythromycin-resistant <italic>Streptococcus pyogenes<\/italic> strains in Italy and heterogeneity of inducibly resistant strains","volume":"43","author":"E Giovanetti","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/10766290152045039","article-title":"Macrolide resistance in <italic>Streptococcus pyogenes<\/italic> isolates from throat infections in the region of Aachen, Germany","volume":"7","author":"CM Brandt","year":"2001","journal-title":"Microb Drug Resist"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00215250","article-title":"Application of the polymerase chain reaction to study the M protein (-like) gene family in beta-hemolytic streptococci","volume":"180","author":"A Podbielski","year":"1991","journal-title":"Med Microbiol Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"KJ Rothman","year":"1990","journal-title":"Epidemiology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.diagmicrobio.2007.10.020","article-title":"Evolution of macrolide resistance in <italic>Streptococcus pneumoniae<\/italic> clinical isolates in the prevaccine era","volume":"60","author":"GL Daikos","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1469-0691.2008.02104.x","article-title":"Decrease in macrolide resistance and clonal instability among <italic>Streptococcus pyogenes<\/italic> in Portugal","volume":"14","author":"C Silva-Costa","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/jac\/dkq006","article-title":"Molecular characterization of macrolide- and multidrug-resistant <italic>Streptococcus pyogenes<\/italic> isolated from adult patients in Barcelona, Spain (1993\u20132008)","volume":"65","author":"C Ardanuy","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3201\/eid1809.120049","article-title":"Antimicrobial drug use and macrolide-resistant <italic>Streptococcus pyogenes<\/italic>, Belgium","volume":"18","author":"L Van Heirstraeten","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1128\/AAC.01133-12","article-title":"Differences between macrolide-resistant and -susceptible <italic>Streptococcus pyogenes<\/italic>: importance of clonal properties in addition to antibiotic consumption","volume":"56","author":"C Silva-Costa","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.diagmicrobio.2009.03.004","article-title":"Macrolide resistance in <italic>Streptococcus pyogenes<\/italic>: prevalence, resistance determinants, and <italic>emm<\/italic> types","volume":"64","author":"AG Michos","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1128\/JCM.41.6.2385-2390.2003","article-title":"Survey of <italic>emm<\/italic> gene sequences from pharyngeal <italic>Streptococcus pyogenes<\/italic> isolates collected in Spain and their relationship with erythromycin susceptibility","volume":"41","author":"S Albert\u00ed","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1128\/JCM.41.3.1307-1310.2003","article-title":"<italic>emm<\/italic> Gene distribution among erythromycin-resistant and -susceptible Italian isolates of <italic>Streptococcus pyogenes<\/italic>","volume":"41","author":"C Zampaloni","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1099\/jmm.0.46481-0","article-title":"Superantigen gene profile, <italic>emm<\/italic> type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain","volume":"55","author":"A Rivera","year":"2006","journal-title":"J Med Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/599344","article-title":"Seven-year surveillance of North American pediatric group A streptococcal pharyngitis isolates","volume":"49","author":"ST Shulman","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1086\/426025","article-title":"Community-based surveillance in the United States of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons","volume":"39","author":"RR Tanz","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref35","first-page":"2010","article-title":"Group A <italic>Streptococcus emm<\/italic> gene types in pharyngeal isolates, Ontario, Canada, 2002\u20132010","volume":"17","author":"PR Shea","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1086\/519936","article-title":"Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden","volume":"45","author":"J Darenberg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1128\/AAC.46.12.3987-3990.2002","article-title":"Erythromycin-resistant pharyngeal isolates of <italic>Streptococcus pyogenes<\/italic> recovered in Italy","volume":"46","author":"G Dicuonzo","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(09)70178-1","article-title":"Global <italic>emm<\/italic> type distribution of group A streptococci: systematic review and implications for vaccine development","volume":"9","author":"AC Steer","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/01.inf.0000190023.89759.96","article-title":"Age influences the <italic>emm<\/italic> type distribution of pediatric group A streptococcal pharyngeal isolates","volume":"24","author":"P Jaggi","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00431-008-0819-6","article-title":"Age-associated differences in prevalence of group A streptococcal type-specific M antibodies in children","volume":"168","author":"P Jaggi","year":"2009","journal-title":"Eur J Pediatr"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10096-004-1274-6","article-title":"Incidence and clinical profile of acute rheumatic fever in Greece","volume":"24","author":"DA Kafetzis","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/521264","article-title":"The epidemiology of invasive group A streptococcal infection and possible vaccine implications: United States, 2000\u20132004","volume":"45","author":"RE O'Loughlin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1128\/JCM.02155-08","article-title":"Clinical and microbiological characteristics of severe <italic>Streptococcus pyogenes<\/italic> disease in Europe","volume":"47","author":"B Luca-Harari","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3201\/eid\/1706.100804","article-title":"Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand","volume":"17","author":"A Safar","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci","volume":"29","author":"JB Dale","year":"2011","journal-title":"Vaccine"}],"updated-by":[{"DOI":"10.1371\/annotation\/4920480a-89ff-479f-992d-8bda2bd599da","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T00:00:00Z","timestamp":1379548800000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0071558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T19:15:05Z","timestamp":1688411705000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0071558"}},"subtitle":[],"editor":[{"given":"Herminia","family":"de Lencastre","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,19]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0071558","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,19]]}}}